Absolutely. The revisions that have taken place under the Medical Device Directives are meant to be on par or if not more stringent then the US FDA. Notified bodies showing up unannounced and greater scrutiny, which wasn’t existent at this level before, is forcing companies to take higher consideration into introducing their products to market whether its combination product or not.